BD began operations in Drogheda in 1964 and is the longest established medical technology multinational company supported by the Industrial Development Agency (IDA). BD opened a second plant in Dun Laoghaire in 1969. The company's two Irish plants manufacture healthcare products such as pen needles, an insulin injection system for the treatment of diabetes.
As well as manufacturing plants in Drogheda and Dun Laoghaire, BD has a trading office in Shannon, Co Clare. In recent years, it has also acquired Clearstream Technologies, continuing to operate its plant in Enniscorthy, and Bard, likewise taking over its operations in Ireland.
Financial Data
-
30th Sep 22 Source: CRO
- €62.3 million turnover
-
€37.8 million
profit - 200 employees
-
31st Dec 19 Source: Estimated
- €1.9 billion turnover
- 4,500 employees
- 11 more years available »
Ranking
By Turnover
(€62.3 million)- 665th in Top Companies
- 70th in Health
- 62nd in Pharma
By Employees
(200)- 592nd in Top Companies
- 73rd in Health
- 50th in Pharma
-
- 200
- €62.3 million
Employees
- Roland Goette CEO/Managing Director
Latest News
- May 24 Harsh winter may compel Europe to ration gas, warns International Energy Agency
- May 24 Hungary and Poland hold up EU decisions on oil and corporate tax
- May 24 Over 700 objections lodged against €466m Dundrum apartment ‘concrete jungle’
- May 24 Stripe unveils new third party app marketplace
- May 24 Shares in UK energy companies slide over windfall tax fears